Back to Trades
Buy4
ABBOTT LABORATORIES
ABT
Total Value
$1.6M
Net $926.5K bought
Purchases
$926.5K
1 transaction
Company Information
- Company Name
- ABBOTT LABORATORIES
- Ticker Symbol
- ABT
- CIK
- 0000001800
Insider Information
- Name
- STARKS DANIEL J
- Role
- Insider
- Location
- ABBOTT PARK, IL
Filing Details
- Filing Date
- Apr 28, 2026
- Transaction Date
- Apr 24, 2026
- Accession Number
- 0000902132-26-000005
- Form Type
- 4
- Net Trading Amount
- $926.5K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 24, 2026 | Common shares without par value | 2,286 | — | Grant/Award | — |
| Apr 27, 2026 | Common shares without par value | 10,000 | $92.65 | Purchase | $926.5K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Apr 24, 2026 | Derivative | 7,105 | $91.86 | Grant/Award | $652.7K |
Footnotes
- (F1)Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
- (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.43 to $93.04, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- (F3)Held in the Alynne Starks 2012 Irrevocable Trust. The reporting person is the sole trustee of the trust.
- (F4)Stock option granted under the Program, in a transaction exempt from Section 16 under Rule 16b-3.